Articles with public access mandates - W. Kimryn RathmellLearn more
Not available anywhere: 4
Review
Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: a phase II trial
WY Kim, YE Whang, RS Pruthi, MQ Baggstrom, WK Rathmell, ...
Urologic Oncology: Seminars and Original Investigations 29 (6), 608-613, 2011
Mandates: US National Institutes of Health
Review
Summary from the Kidney Cancer Association’s inaugural think thank: coalition for a cure
B Rini, EJ Abel, L Albiges, A Bex, J Brugarolas, RM Bukowski, ...
Clinical Genitourinary Cancer 19 (2), 167-175, 2021
Mandates: Cancer Research UK, National Institute for Health Research, UK
Review
OPtimal Treatment by Invoking biologic clusters in renal cell carcinoma (OPTIC RCC).
K Beckermann, S Haake, A Reddy, Y Shyr, WK Rathmell, S Pal, ...
Oncologist 28, 2023
Mandates: US Department of Defense
Review
Distinct molecular subtypes of clear cell renal cell carcinoma identified by simplified mRNA profiling predicts clinical outcome
EM Wallen, AR Brannon, RS Pruthi, A Reddy, M Seiler, S Ganeson, ...
The Journal of Urology 181 (4S), 111-112, 2009
Mandates: US National Institutes of Health
Available somewhere: 209
Review
Comprehensive molecular portraits of human breast tumours
Brigham & Women’s Hospital & Harvard Medical School Chin Lynda 9 11 Park ...
Nature 490 (7418), 61-70, 2012
Mandates: US National Institutes of Health
Review
Comprehensive molecular characterization of gastric adenocarcinoma
Cancer Genome Atlas Research Network
Nature 513 (7517), 202, 2014
Mandates: US National Institutes of Health
Review
Integrated genomic characterization of endometrial carcinoma
DA Levine, ...
Nature 497 (7447), 67-73, 2013
Mandates: US National Institutes of Health
Review
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
Mandates: US Department of Defense, US National Institutes of Health
Review
Comprehensive molecular profiling of lung adenocarcinoma
Cancer Genome Atlas Research Network
Nature 511 (7511), 543, 2014
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Review
Comprehensive genomic characterization of squamous cell lung cancers
Cancer Genome Atlas Research Network
Nature 489 (7417), 519, 2012
Mandates: US National Institutes of Health
Review
Comprehensive genomic characterization of head and neck squamous cell carcinomas
Cancer Genome Atlas Network
Nature 517 (7536), 576, 2015
Mandates: US National Institutes of Health
Review
Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas
Cancer Genome Atlas Research Network
New England Journal of Medicine 372 (26), 2481-2498, 2015
Mandates: US National Institutes of Health
Review
Comprehensive molecular characterization of clear cell renal cell carcinoma
CGAR Network
Nature 499 (7456), 43, 2013
Mandates: US National Institutes of Health
Review
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
Mandates: US Department of Defense, US National Institutes of Health
Review
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, B áArman Aksoy, M Albert, A Ally, SB Amin, ...
Cell 161 (7), 1681-1696, 2015
Mandates: US National Institutes of Health, Cancer Research UK
Review
Comprehensive molecular characterization of urothelial bladder carcinoma
Cancer Genome Atlas Research Network
Nature 507 (7492), 315, 2014
Mandates: US National Institutes of Health
Review
The molecular taxonomy of primary prostate cancer
A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ...
Cell 163 (4), 1011-1025, 2015
Mandates: US National Institutes of Health
Review
Integrated genomic characterization of papillary thyroid carcinoma
N Agrawal, R Akbani, BA Aksoy, A Ally, H Arachchi, SL Asa, JT Auman, ...
Cell 159 (3), 676-690, 2014
Mandates: US National Institutes of Health
Review
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
Mandates: US National Institutes of Health
Review
Comprehensive molecular characterization of muscle-invasive bladder cancer
AG Robertson, J Kim, H Al-Ahmadie, J Bellmunt, G Guo, AD Cherniack, ...
Cell 171 (3), 540-556. e25, 2017
Mandates: US Department of Defense, US National Institutes of Health
Publication and funding information is determined automatically by a computer program